https://www.selleckchem.com/pr....oducts/Rapamycin.htm
The study aimed to assess the suitability of multiparametric magnetic resonance prostate imaging (mpMRI) in combination with clinical parameters [prostate-specific antigen (PSA), digital rectal examination (DRE)] in the identification of men at risk of the presence of prostate cancer (PCa) and clinically significant prostate cancer (csPCa, Gleason Score ≥3+4) in the cognitive fusion with systematic prostate biopsy. We retrospectively evaluated a population of 215 biopsy - naive patients with a clinical suspicion of prostate cancer. Th
Aimer
Commentaire
Partagez
